BEVA-24042

N/A

Report date: 2025/05/16 16:52:17

Base Information

Drug NameBEVA-24042
Drug Alias NameBevacizumab (Oddifact)贝伐珠单抗 (Oddifact)BEVA-24042
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOddifact SAS
China Registration ClassN/A

Develop Information

Active CompaniesOddifact SAS
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A